People at high risk for recurrent cardiac events following percutaneous coronary intervention (PCI), a procedure to open ...

Taking aspirin was first linked to a lower risk of colorectal cancer in 1988, but the research into its anti-tumour potential ...

For prolonged antithrombotic treatment after percutaneous coronary intervention (PCI), clopidogrel monotherapy was more ...

Two years after percutaneous coronary intervention, people at risk of a cardiac event had better outcomes with clopidogrel ...

People at high risk for recurrent cardiac events following percutaneous coronary intervention (PCI), a procedure to open blocked arteries, experienced significantly better outcomes with clopidogrel ...

Aspirin use is associated with an increased risk for acute kidney injury in critical patients with chest trauma, whereas ibuprofen and ketorolac show no significant association, a study suggests.

People at high risk for recurrent cardiac events following percutaneous coronary intervention (PCI), a procedure to open blocked arteries, ...

The new research suggests a path for aspirin to become a cancer treatment - but people are being warned not to start taking it daily without speaking to a doctor.

Aspirin, one of the world’s most common over-the-counter painkillers, could help fight cancer, a new study, published in ...

The findings support current guidelines recommending low-dose aspirin (81 mg) as an effective preventive measure for ...

Through a mouse study, scientists have found that aspirin may help prevent metastases, or secondary tumors, by boosting the body’s immune response.